Global breast cancer therapeutics market projected to reach US$ 63.9 billion by 2030 with 9.4% CAGR

From GlobeNewswire: 2025-03-19 07:53:00

The global breast cancer therapeutics market is projected to reach US$ 63.9 billion by 2030, with a CAGR of 9.4%. Key players include Eli Lilly, Novartis, and Pfizer, focusing on HER2+ and metastatic breast cancer treatments. North America leads the market, with Asia Pacific showing the highest growth potential.

New therapeutic products like HER2 inhibitors and immunotherapies are driving the growth of the breast cancer therapeutics market. Innovations in targeted therapies and personalized medicine are revolutionizing breast cancer treatment, leading to improved patient outcomes. Regulatory bodies are expediting approvals for new products, increasing treatment options for patients worldwide.

The report from The Insight Partners offers valuable insights into the evolving breast cancer therapeutics market, highlighting opportunities for stakeholders. The market is dynamic, with North America leading due to healthcare expenditure and access to advanced therapies, while Asia Pacific markets show growth potential. The market outlook is positive, with room for innovation and growth in the coming years.



Read more at GlobeNewswire: Breast Cancer Therapeutics Market Size to Reach US$ 63.9